Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel proteasome inhibitor discovered by Vivolux

March 17, 2014

BioMarin Pharmaceutical designs new agent for mucopolysaccharidosis type IIIB

March 17, 2014

High early bactericidal activity of pretomanid combined with bedaquiline and pyrazinamide

March 14, 2014

GSK-744/rilpivirine as maintenance therapy for HIV infection

March 14, 2014

Potent antiviral activity and favorable safety of doravirine in HIV-1-infected patients

March 14, 2014

Favorable 24-week virological efficacy of BMS-663068 supports continued development

March 14, 2014

Researchers identify a new putative compensatory mechanism of miR1246 in colorectal cancer

March 14, 2014

Proteostasis Therapeutics presents data on novel USP14 inhibitor

March 14, 2014

ArmaGen Technologies' re-engineered IDS penetrates BBB

March 14, 2014

Protalix BioTherapeutics presents new preclinical data on PRX-102

March 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...